ERYTHROMYCIN A N-OXIDE (25 mg) ((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-?-D-xylo-hexopyranosyl)oxy]oxacyclotetradecane-2,10-dione N-oxide)

In Stock

Ready to ship

Catalogue No.

1A10240

CAS No.

992-65-4

Molecular Formula

C₃₇H₆₇NO₁₄

Product Type

Pharmaceutical Analytical Impurities

$1,250.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F261D0

CAS RN®

992-65-4

Harmonized System (HS) Code *:

29322090

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₃₇H₆₇NO₁₄

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F261D0	1A10240-F261D0	See Product Information Sheet	India	Chemical Synthesis


Lot No F261D0	USP Certificates/Product Information Sheets and Valid Use Dates Chemical Synthesis
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* No data available

Lot No

F261D0

USP Certificates/Product Information Sheets and Valid Use Dates

Chemical Synthesis

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

No data available

Frequently bought together

ERYTHROMYCIN A N-OXIDE (25 mg) ((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-?-D-xylo-hexopyranosyl)oxy]oxacyclotetradecane-2,10-dione N-oxide)

Catalogue No.

1A10240

CAS No.

992-65-4

Molecular Formula

C₃₇H₆₇NO₁₄

Product Type

Pharmaceutical Analytical Impurities

$1,250.00

RIZATRIPTAN N-METHYL ADDUCT IODIDE (25 mg) (2-{5-[(1H-1,2,4-Triazol-1-yl)methyl]-1H-indol-3-yl}-N,N,N-trimethylethan-1-aminium iodide)

Catalogue No.

1A10050

CAS No.

Molecular Formula

C₁₆H₂₂IN₅

Product Type

Pharmaceutical Analytical Impurities

$690.00

DIDEHYDROGLYCOPYRROLATE (25 mg) (3-[2-(Cyclopent-1-en-1-yl)-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidin-1-ium bromide)

Catalogue No.

1A10070

CAS No.

Molecular Formula

C₁₉H₂₆BrNO₃

Product Type

Pharmaceutical Analytical Impurities

$1,025.00

2-CHLORO BUPROPION HYDROCHLORIDE (25 mg) (2-(tert-Butylamino)-1-(2-chlorophenyl)propan-1-one hydrochloride)

ERYTHROMYCIN A N-OXIDE (25 mg) ((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-?-D-xylo-hexopyranosyl)oxy]oxacyclotetradecane-2,10-dione N-oxide)

(CIS-2-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-2-(2,4-DICHLOROPHENYL)-1,3-DIOXOLAN-4-YL)METHYL METHANESULFONATE (25 mg) ((cis-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan -4-yl)methyl methanesulfonate)

11-DEOXY PREDNISOLONE (25 mg) (17,21-Dihydroxypregna-1,4-diene-3,20-dione )

THYROXINE T4-ACETAMIDE (25 mg) (2-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]acetamide)

SUMATRIPTAN HYDROXY OXINDOLE (25 mg) (1-[3-[2-(dimethylamino)ethyl]-3-hydroxy-2-oxo-1H-indol-5-yl]-N-methylmethanesulfonamide)

5,6,7,8-TETRADEHYDRO RISPERIDONE (25 mg) (3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methylpyrido[1,2-a]pyrimidin-4-one )

ESMOLOL ACID (25 mg) (3-{4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl}propanoic acid)

6-DEHYDRO CORTISOL (25 mg) (11?,17,21-Trihydroxypregna-4,6-diene-3,20-dione )

TAZOBACTAM DIPHENYLMETHYL ESTER (25 mg) (Benzhydryl (2S,3S,5R)-3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide )